EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alzheimer’s Disease Risk Variants Interact with Amyloid-Beta to Modulate Monocyte Function

Zena K Chatila iD, Elizabeth M Bradshaw iD

Cells · 2025

DOI: 10.3390/cells14241990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Zena K Chatila und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Neurobiology, Department of Neurology, Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032…. Hauptthemen laut MEDLINE: Alzheimer Disease, Monocytes, Amyloid beta-Peptides, Genetic Predisposition to Disease. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Alzheimer's Association, US National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While genetics implicate a central role for dysregulated innate immunity in Alzheimer’s disease (AD), the contributions of peripheral myeloid cells, such as monocytes, have been largely overlooked in favor of microglia. Here, we investigate whether AD-associated loci, specifically rs3865444 in the CD33 locus and rs1057233 in the SPI1 locus, converge on shared functional pathways in monocytes in the context of amyloid-beta peptide 1-42 (Aβ1-42) as an immune stimulus. To do so, we isolated monocytes from peripheral blood mononuclear cells (PBMCs) from healthy individuals and exposed them to aggregated Aβ1-42. In this study, we identify functional convergence of the CD33 and SPI1 AD risk variants in the context of aggregated Aβ, both resulting in reduced phagocytosis and loss of surface TREM2 expression, demonstrating an interaction between genetics and environment to reduce myeloid cell fitness. These findings highlight that peripheral monocytes, like brain-resident microglia, are genetically and functionally linked to AD risk, underscoring their importance as accessible immune cells that contribute to disease susceptibility and progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMonocytesAmyloid beta-PeptidesGenetic Predisposition to DiseaseHumansSialic Acid Binding Ig-like Lectin 3Receptors, ImmunologicPhagocytosisMembrane GlycoproteinsPolymorphism, Single NucleotideMaleFemaleMicrogliaLeukocytes, MononuclearPeptide Fragments

Stichwörter der Autor:innen

Amyloid-beta1-42 uptakeCD33PU.1TREM2human monocytes

Substanzen

Amyloid beta-PeptidesSialic Acid Binding Ig-like Lectin 3Receptors, ImmunologicTREM2 protein, humanMembrane GlycoproteinsCD33 protein, humanPeptide Fragments

Autor:innen und Institutionen

  • Division of Translational Neurobiology, Department of Neurology, Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032, USA.
  • The Carol and Gene Ludwig Center for Research on Neurodegeneration, Department of Neurology, Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032, USA.
  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032, USA.

ORCID-Profile: Zena K Chatila, Elizabeth M Bradshaw

Förderung

  • NIA NIH HHS
  • Alzheimer's Association
  • US National Institutes of Health
  • Alzheimer’s Association

Zitieren

APA

Chatila, Z. K., & Bradshaw, E. M. (2025). Alzheimer’s Disease Risk Variants Interact with Amyloid-Beta to Modulate Monocyte Function. Cells. https://doi.org/10.3390/cells14241990

Vancouver

Chatila ZK, Bradshaw EM. Alzheimer’s Disease Risk Variants Interact with Amyloid-Beta to Modulate Monocyte Function. Cells. 2025. doi:10.3390/cells14241990

BibTeX
@article{Chatila2025,
  author = {Chatila, Zena K and Bradshaw, Elizabeth M},
  title = {Alzheimer’s Disease Risk Variants Interact with Amyloid-Beta to Modulate Monocyte Function},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14241990}
}
Kostenlos starten →